Novel compositions for treatment of diseases related to activated lymphocytes

Details for Australian Patent Application No. 2009219435 (hide)

Owner Immune Control, Inc.

Inventors Rao, Nallaganchu; Self, Christopher; Roth, Stephen; Olson, Gary; Buck, Clayton

Agent Pizzeys

Pub. Number AU-A-2009219435

PCT Pub. Number WO2009/108635

Priority 61/067,695 29.02.08 US

Filing date 24 February 2009

Wipo publication date 3 September 2009

International Classifications

C07D 279/18 (2006.01) Heterocyclic compounds containing six-membered rings having one nitrogen atom and one sulfur atom as the only ring hetero atoms

Event Publications

16 September 2010 PCT application entered the National Phase

  PCT publication WO2009/108635 Priority application(s): WO2009/108635

28 October 2010 Amendment Made

  The nature of the amendment is as shown in the statement(s) filed 23 Sep 2010

19 April 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(a). A direction to request examination has been given for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2009219437-Drug selection for breast cancer therapy using antibody-based arrays

2009219432-Compositions and methods for using stromal cells to enhance treatment of central nervous system injuries